Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

This is a Phase 1/2, first-in-human, open-label, dose-escalating and expansion trial designed to assess the safety and efficacy of VNX-202 in patients with HER2 positive cancers.

Participants needed: 27
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Vironexis Biotherapeutics Inc.Updated: Jun 24, 2026Locations: 10
Eligibility criteria

Age: ≥18 years of age [+8]

Hepatoxicity (AST or ALT > 2x upper limit of normal) [+5]

Read more
Status: Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

This is a Phase 1/2, first-in-human, open-label, dose-escalating trial designed to assess the safety and efficacy of VNX-101 in patients with relapsed or refractory CD19-positive hematologic malignancies.

Participants needed: 32
Trial details
Phase: Phase 1, Phase 2Age: 13-90Biological sex: AllType: InterventionalSponsor: Vironexis Biotherapeutics Inc.Updated: Mar 30, 2026Locations: 9
Eligibility criteria

Age: Part 1: 18-90 years of age, Part 2: 13-90 years of age [+5]

Hepatoxicity (AST or ALT > 2x upper limit of normal) [+5]

Read more